Reference
Dujmovic D, et al. Polatuzumab-vedotin combined with immunochemotherapy in R/R patients with DLBCL: A retrospective, non-interventional, real-life study of krohem, the croatian cooperative group for hematologic diseases. HemaSphere 4 (Suppl. 1): 586 abstr. EP1250, Jun 2020. Available from: URL: http://doi.org/10.1097/HS9.0000000000000404 [abstract]
Rights and permissions
About this article
Cite this article
Anti-CD20 monoclonal antibody/bendamustine/polatuzumab vedotin. Reactions Weekly 1817, 30 (2020). https://doi.org/10.1007/s40278-020-81989-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-81989-5